Clinical Trial Update: Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a monovalent influenza A (H5N1) vaccine with and without AS03 adjuvant; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Virus Infection H5n1 Subtype

Drugs mentioned

• Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Influenza A Virus, H5N1 Subtype | Phase 2 | Status: COMPLETED | Results posted: 2019-02-12